Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline

Biomedicine and Pharmacotherapy

Volumn 57, Issue 8, 2003, Pages 341-350

  Umezawa, K ^a   Hiroki, A ^a   Kawakami, M ^a   Naka, H ^a   Takei, I ^a   Ogata, T ^b   Kojima, I ^b   Koyano, T ^c   Kowithayakorn, T ^d   Pang, H S ^e   Kam, T S ^e  

^a KEIO UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Temko Corporation   (Japan)

^d KHON KAEN UNIVERSITY   (Thailand)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

AR42J cell; Conophylline; Insulin; Neurogenin3; P38; Smad2; Cell

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVIN A; ANTIDIABETIC AGENT; CONOFOLINE; CONOFOLINE QUINONE; CONOPHYLLIDINE; CONOPHYLLIDINE QUINONE; CONOPHYLLINE; CONOPHYLLINE QUINONE; CONOPHYLLININE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROGENIC DIFFERENTIATION FACTOR; PACHYSIPHINE; SMAD2 PROTEIN; TABERHANINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX22; TRANSCRIPTION FACTOR PAX4; UNCLASSIFIED DRUG; VINCA ALKALOID;

ACINAR CELL CARCINOMA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; INSULIN SYNTHESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

EID: 12444315617     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00096-9     Document Type: Article

References (40)

1. Graeme I.B., Kenneth S.P. Diabetes mellitus and genetically programmed defects in β-cell function. Nature. 414:2001;788-791.
2. Saktiek A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes [Review]. Cell. 104:2001;517-529.
3. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., et al. Beneficial effect of antioxidants in diabetes: possible protection of pancreatic β-cell against glucose toxicity. Diabetes. 48:1999;2398-2406.
4. Iwahashi H., Hanafusa T., Nakajima H., Miyagawa J., Itoh N., Tomita K., et al. Cytokine-induced apoptosis should be apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia. 39:1996;530-536.
5. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 127:2000;2317-2322.
6. Bonner-Weir S., Baxter L.A., Schuppin G.T., Smith F.E. A second pathway for generation of adult exocrine and endocrine pancreas: a possible recapitulation of embryonic development. Diabetes. 42:1993;1715-1720.
7. Hunziker E., Stein M. Nestin-expressing cells in the pancreatic islet of Langerhans. Biochem Biophys Res Commun. 271:2000;116-119.
8. Zulewski H., Abraham E.J., Gerlach M.J., Daniel P.B., Moritz W.M., Iler B., et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. Diabetes. 50:2001;521-533.
9. Lumelysky N., Blondel O., Lasng P., Velasco I., Ravin R., McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 292:2001;1389-1394.
10. Demeterco C., Beattie G.M., Dib S.A., Lopez A.D., Hayek A. A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endo. 85:2000;3892-3897.
11. Ishiyama N., Kanzaki M., Seno M., Yamada H., Kojima I. Studies on the betacellulin receptor in pancreatic AR42J cells. Diabetologia. 41:1998;623-628.
12. Garcia-Ocaña A., Takane K.K., Syed M.A., Philbrick W.M., Vasavada R.C., Stewart A.F. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass and induces mild hypoglycemia. J Biol Chem. 275:2000;1226-1232.
13. Assady S., Maor G., Itskovitz-Eldor J., Skorecki K.L., Tzukerman M. Insulin production by human embryonic stem cells. Diabetes. 50:2000;1691-1697.
14. Sjoholm A., Korsgren O., Andersson A. Polyamine requirements in nicotinamide-stimulated beta-cell differentiation in fetal porcine islet-like cell clusters. Endocrinology. 135:1994;1559-1565.
15. Akiyama T., Takasawa S., Nata K., Kobayashi S., Abe M., Shervani N.J., et al. Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(ADP-ribosyl)action. Proc Natl Acad Sci USA. 98:2001;48-53.
16. Watanabe T., Yonemura Y., Yonekura H., Suzuki Y., Miyashita H., Sugiyama K., et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA. 91:1994;3589-3592.
17. Korsgren O., Andersson A., Sandler S. In vitro screening putative compounds inducing fetal porcine pancreatic β-cell differentiation: implications for cell transplantation in insulin dependent diabetes mellitus. Upsala J Med Sci. 98:1993;39-52.
18. Longsdon C.D., Moessner J., Williams J.A., Goldfine I.D. Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. J Cell Biol. 100:1985;1200-1208.
19. Rosewicz S., Vogt D., Hrth N., Grund C., Franke W.W., Ruppert S., et al. An amphicrine pancreatic cell line: AR42J cells combine exocrine and neuroendocrine properties. Eur J Cell Biol. 59:1992;80-91.
20. Ohishi H., Ohgushi N., Tanaka S., Mogami H., Nobusawa R., Mashima H., et al. Conversion of amylase-secreting rat pancreatic AR42J cells to neuron like cells by activin A. J Clin Invest. 95:1995;2304-2314.
21. Mashima H., Shibata H., Mine T., Kojima I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology. 137:1996;3969-3976.
22. Mahima H., Ohnishi H., Wakabayashi K., Mine T., Miyagawa J., Hanafusa T., et al. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest. 97:1996;1647-1654.
23. Zhang Y.Q., Mashima H., Kojima I. Changes in the expression of transcription factors in pancreatic AR42J cells during differentiation into insulin-producing cells. Diabetes. 50:2001;S10-S14.
24. Kam T.S., Loh K.Y., Wei C. Conophylline and conophyllidine: new dimeric alkaloids from Tabernaemontana divaricata. J Nat Prod. 56:1993;1865-1871.
25. Kam T.S., Anuradha S. Alkaloids from Tabernaemontana divaricata. Phytochemistry. 40:1995;313-316.
26. Kam T.S., Pang H.S., Lim T.M. Biologically active indole and bisindole alkaloids from Tabernaemontana divaricata. Org Biomol Chem. 1:2003;1292-1297.
27. Mizutani Y., Masuoka S., Imoto M., Kawada M., Umezawa K. Induction of erythroid differentiation in leukamic K562 cells by an S-adenosyl homocysteine hydrolase inhibitor, aristeromycin. Biochem Biophys Res Commun. 209:1995;25-30.
28. Yoshida M., Nomura S., Beppu T. Effect of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res. 47:1987;3688-3691.
29. Fujiwara S., Watanabe T., Nagatsu T., Gohda J., Imoto M., Umezawa K. Enhancement or induction of neurite formation by a protein tyrosine phosphatase inhibitor, 3,4-dephostatin, in growth factor-treated PC12h cells. Biochem Biophys Res Commun. 238:1997;213-217.
30. Gradwohl G., Dietich A., LeMeur M., Guillemont F. Neurogenin3 is required for development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA. 97:2000;1607-1611.
31. Huang H.P., Liu M., El-Hodiri H.M., Chu K., Jamrich M., Tsai M.J. Regulation of the pancreatic islet-specific gene Beta2 (neuroD) by neurogenin3. Mol Cell Biol. 20:2000;3292-3307.
32. Zhang Y.Q., Kanzaki M., Furukawa M., Shibata H., Ozaki M., Kojima I. Involvement of Smad 2 proteins in the differentiation of pancreatic AR42J cells. Diabetologia. 42:1999;719-727.
33. Mikkola I., Bruun J.A., Bjorkoy G., Holm T., Johansen T. Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem. 274:1999;15115-15126.
34. Umezawa K., Ohse T., Yamamoto T., Koyano T., Takahashi Y. Isolation of a new vinca alkaloid from the leaves of Ervatamia microphylla as an inhibitor of ras functions. Anticancer Res. 14:1994;2413-2418.
35. Teitelman G. Cellular and molecular analysis of pancreatic islet cell lineage and differentiation [Review]. Recent Prog Horm Res. 47:1991;259-294.
36. Herrera P.L., Huarte J., Zufferey R., Nichol A., Mermillod B., Philippe J., et al. Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes. Proc Natl Acad Sci USA. 91:1994;12999-13003.
37. Ueda Y. Activin A increases Pax4 gene expression in pancreatic beta cell lines. FEBS Lett. 480:2000;101-105.
38. Ono K., Han J. The p38 signal transduction pathway: activation and function [Review]. Cell Signal. 12:2000;1-13.
39. Cocolakis E., Lemay S., Ali S., Lebrun J.J. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem. 276:2001;18430-18436.
40. Odorico J.S., Kaufman D.S., Thomson J.A. Multilineage differentiation from human embryonic stem cell lines [Review]. Stem Cells. 19:2001;193-204.